These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 27665254)

  • 1. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
    Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T
    Lancet Infect Dis; 2016 Dec; 16(12):1385-1398. PubMed ID: 27665254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.
    GBD 2019 Europe Hepatitis B & C Collaborators
    Lancet Public Health; 2023 Sep; 8(9):e701-e716. PubMed ID: 37633679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
    Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
    Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.
    Degenhardt L; Whiteford HA; Ferrari AJ; Baxter AJ; Charlson FJ; Hall WD; Freedman G; Burstein R; Johns N; Engell RE; Flaxman A; Murray CJ; Vos T
    Lancet; 2013 Nov; 382(9904):1564-74. PubMed ID: 23993281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Risk Factors Collaborators
    Lancet; 2017 Sep; 390(10100):1345-1422. PubMed ID: 28919119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Alcohol and Drug Use Collaborators
    Lancet Psychiatry; 2018 Dec; 5(12):987-1012. PubMed ID: 30392731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Hepatitis B Collaborators
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):796-829. PubMed ID: 35738290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States.
    Kim JH; Psevdos G; Suh J; Sharp VL
    World J Gastroenterol; 2008 Nov; 14(43):6689-93. PubMed ID: 19034972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Risk Factors Collaborators
    Lancet; 2016 Oct; 388(10053):1659-1724. PubMed ID: 27733284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
    Whiteford HA; Degenhardt L; Rehm J; Baxter AJ; Ferrari AJ; Erskine HE; Charlson FJ; Norman RE; Flaxman AD; Johns N; Burstein R; Murray CJ; Vos T
    Lancet; 2013 Nov; 382(9904):1575-86. PubMed ID: 23993280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    Liver Int; 2022 Oct; 42(10):2145-2153. PubMed ID: 35753064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Mental Disorders Collaborators
    Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.
    ; Murray CJ; Barber RM; Foreman KJ; Abbasoglu Ozgoren A; Abd-Allah F; Abera SF; Aboyans V; Abraham JP; Abubakar I; Abu-Raddad LJ; Abu-Rmeileh NM; Achoki T; Ackerman IN; Ademi Z; Adou AK; Adsuar JC; Afshin A; Agardh EE; Alam SS; Alasfoor D; Albittar MI; Alegretti MA; Alemu ZA; Alfonso-Cristancho R; Alhabib S; Ali R; Alla F; Allebeck P; Almazroa MA; Alsharif U; Alvarez E; Alvis-Guzman N; Amare AT; Ameh EA; Amini H; Ammar W; Anderson HR; Anderson BO; Antonio CA; Anwari P; Arnlöv J; Arsic Arsenijevic VS; Artaman A; Asghar RJ; Assadi R; Atkins LS; Avila MA; Awuah B; Bachman VF; Badawi A; Bahit MC; Balakrishnan K; Banerjee A; Barker-Collo SL; Barquera S; Barregard L; Barrero LH; Basu A; Basu S; Basulaiman MO; Beardsley J; Bedi N; Beghi E; Bekele T; Bell ML; Benjet C; Bennett DA; Bensenor IM; Benzian H; Bernabé E; Bertozzi-Villa A; Beyene TJ; Bhala N; Bhalla A; Bhutta ZA; Bienhoff K; Bikbov B; Biryukov S; Blore JD; Blosser CD; Blyth FM; Bohensky MA; Bolliger IW; Bora Başara B; Bornstein NM; Bose D; Boufous S; Bourne RR; Boyers LN; Brainin M; Brayne CE; Brazinova A; Breitborde NJ; Brenner H; Briggs AD; Brooks PM; Brown JC; Brugha TS; Buchbinder R; Buckle GC; Budke CM; Bulchis A; Bulloch AG; Campos-Nonato IR; Carabin H; Carapetis JR; Cárdenas R; Carpenter DO; Caso V; Castañeda-Orjuela CA; Castro RE; Catalá-López F; Cavalleri F; Çavlin A; Chadha VK; Chang JC; Charlson FJ; Chen H; Chen W; Chiang PP; Chimed-Ochir O; Chowdhury R; Christensen H; Christophi CA; Cirillo M; Coates MM; Coffeng LE; Coggeshall MS; Colistro V; Colquhoun SM; Cooke GS; Cooper C; Cooper LT; Coppola LM; Cortinovis M; Criqui MH; Crump JA; Cuevas-Nasu L; Danawi H; Dandona L; Dandona R; Dansereau E; Dargan PI; Davey G; Davis A; Davitoiu DV; Dayama A; De Leo D; Degenhardt L; Del Pozo-Cruz B; Dellavalle RP; Deribe K; Derrett S; Des Jarlais DC; Dessalegn M; Dharmaratne SD; Dherani MK; Diaz-Torné C; Dicker D; Ding EL; Dokova K; Dorsey ER; Driscoll TR; Duan L; Duber HC; Ebel BE; Edmond KM; Elshrek YM; Endres M; Ermakov SP; Erskine HE; Eshrati B; Esteghamati A; Estep K; Faraon EJ; Farzadfar F; Fay DF; Feigin VL; Felson DT; Fereshtehnejad SM; Fernandes JG; Ferrari AJ; Fitzmaurice C; Flaxman AD; Fleming TD; Foigt N; Forouzanfar MH; Fowkes FG; Paleo UF; Franklin RC; Fürst T; Gabbe B; Gaffikin L; Gankpé FG; Geleijnse JM; Gessner BD; Gething P; Gibney KB; Giroud M; Giussani G; Gomez Dantes H; Gona P; González-Medina D; Gosselin RA; Gotay CC; Goto A; Gouda HN; Graetz N; Gugnani HC; Gupta R; Gupta R; Gutiérrez RA; Haagsma J; Hafezi-Nejad N; Hagan H; Halasa YA; Hamadeh RR; Hamavid H; Hammami M; Hancock J; Hankey GJ; Hansen GM; Hao Y; Harb HL; Haro JM; Havmoeller R; Hay SI; Hay RJ; Heredia-Pi IB; Heuton KR; Heydarpour P; Higashi H; Hijar M; Hoek HW; Hoffman HJ; Hosgood HD; Hossain M; Hotez PJ; Hoy DG; Hsairi M; Hu G; Huang C; Huang JJ; Husseini A; Huynh C; Iannarone ML; Iburg KM; Innos K; Inoue M; Islami F; Jacobsen KH; Jarvis DL; Jassal SK; Jee SH; Jeemon P; Jensen PN; Jha V; Jiang G; Jiang Y; Jonas JB; Juel K; Kan H; Karch A; Karema CK; Karimkhani C; Karthikeyan G; Kassebaum NJ; Kaul A; Kawakami N; Kazanjan K; Kemp AH; Kengne AP; Keren A; Khader YS; Khalifa SE; Khan EA; Khan G; Khang YH; Kieling C; Kim D; Kim S; Kim Y; Kinfu Y; Kinge JM; Kivipelto M; Knibbs LD; Knudsen AK; Kokubo Y; Kosen S; Krishnaswami S; Kuate Defo B; Kucuk Bicer B; Kuipers EJ; Kulkarni C; Kulkarni VS; Kumar GA; Kyu HH; Lai T; Lalloo R; Lallukka T; Lam H; Lan Q; Lansingh VC; Larsson A; Lawrynowicz AE; Leasher JL; Leigh J; Leung R; Levitz CE; Li B; Li Y; Li Y; Lim SS; Lind M; Lipshultz SE; Liu S; Liu Y; Lloyd BK; Lofgren KT; Logroscino G; Looker KJ; Lortet-Tieulent J; Lotufo PA; Lozano R; Lucas RM; Lunevicius R; Lyons RA; Ma S; Macintyre MF; Mackay MT; Majdan M; Malekzadeh R; Marcenes W; Margolis DJ; Margono C; Marzan MB; Masci JR; Mashal MT; Matzopoulos R; Mayosi BM; Mazorodze TT; Mcgill NW; Mcgrath JJ; Mckee M; Mclain A; Meaney PA; Medina C; Mehndiratta MM; Mekonnen W; Melaku YA; Meltzer M; Memish ZA; Mensah GA; Meretoja A; Mhimbira FA; Micha R; Miller TR; Mills EJ; Mitchell PB; Mock CN; Mohamed Ibrahim N; Mohammad KA; Mokdad AH; Mola GL; Monasta L; Montañez Hernandez JC; Montico M; Montine TJ; Mooney MD; Moore AR; Moradi-Lakeh M; Moran AE; Mori R; Moschandreas J; Moturi WN; Moyer ML; Mozaffarian D; Msemburi WT; Mueller UO; Mukaigawara M; Mullany EC; Murdoch ME; Murray J; Murthy KS; Naghavi M; Naheed A; Naidoo KS; Naldi L; Nand D; Nangia V; Narayan KM; Nejjari C; Neupane SP; Newton CR; Ng M; Ngalesoni FN; Nguyen G; Nisar MI; Nolte S; Norheim OF; Norman RE; Norrving B; Nyakarahuka L; Oh IH; Ohkubo T; Ohno SL; Olusanya BO; Opio JN; Ortblad K; Ortiz A; Pain AW; Pandian JD; Panelo CI; Papachristou C; Park EK; Park JH; Patten SB; Patton GC; Paul VK; Pavlin BI; Pearce N; Pereira DM; Perez-Padilla R; Perez-Ruiz F; Perico N; Pervaiz A; Pesudovs K; Peterson CB; Petzold M; Phillips MR; Phillips BK; Phillips DE; Piel FB; Plass D; Poenaru D; Polinder S; Pope D; Popova S; Poulton RG; Pourmalek F; Prabhakaran D; Prasad NM; Pullan RL; Qato DM; Quistberg DA; Rafay A; Rahimi K; Rahman SU; Raju M; Rana SM; Razavi H; Reddy KS; Refaat A; Remuzzi G; Resnikoff S; Ribeiro AL; Richardson L; Richardus JH; Roberts DA; Rojas-Rueda D; Ronfani L; Roth GA; Rothenbacher D; Rothstein DH; Rowley JT; Roy N; Ruhago GM; Saeedi MY; Saha S; Sahraian MA; Sampson UK; Sanabria JR; Sandar L; Santos IS; Satpathy M; Sawhney M; Scarborough P; Schneider IJ; Schöttker B; Schumacher AE; Schwebel DC; Scott JG; Seedat S; Sepanlou SG; Serina PT; Servan-Mori EE; Shackelford KA; Shaheen A; Shahraz S; Shamah Levy T; Shangguan S; She J; Sheikhbahaei S; Shi P; Shibuya K; Shinohara Y; Shiri R; Shishani K; Shiue I; Shrime MG; Sigfusdottir ID; Silberberg DH; Simard EP; Sindi S; Singh A; Singh JA; Singh L; Skirbekk V; Slepak EL; Sliwa K; Soneji S; Søreide K; Soshnikov S; Sposato LA; Sreeramareddy CT; Stanaway JD; Stathopoulou V; Stein DJ; Stein MB; Steiner C; Steiner TJ; Stevens A; Stewart A; Stovner LJ; Stroumpoulis K; Sunguya BF; Swaminathan S; Swaroop M; Sykes BL; Tabb KM; Takahashi K; Tandon N; Tanne D; Tanner M; Tavakkoli M; Taylor HR; Te Ao BJ; Tediosi F; Temesgen AM; Templin T; Ten Have M; Tenkorang EY; Terkawi AS; Thomson B; Thorne-Lyman AL; Thrift AG; Thurston GD; Tillmann T; Tonelli M; Topouzis F; Toyoshima H; Traebert J; Tran BX; Trillini M; Truelsen T; Tsilimbaris M; Tuzcu EM; Uchendu US; Ukwaja KN; Undurraga EA; Uzun SB; Van Brakel WH; Van De Vijver S; van Gool CH; Van Os J; Vasankari TJ; Venketasubramanian N; Violante FS; Vlassov VV; Vollset SE; Wagner GR; Wagner J; Waller SG; Wan X; Wang H; Wang J; Wang L; Warouw TS; Weichenthal S; Weiderpass E; Weintraub RG; Wenzhi W; Werdecker A; Westerman R; Whiteford HA; Wilkinson JD; Williams TN; Wolfe CD; Wolock TM; Woolf AD; Wulf S; Wurtz B; Xu G; Yan LL; Yano Y; Ye P; Yentür GK; Yip P; Yonemoto N; Yoon SJ; Younis MZ; Yu C; Zaki ME; Zhao Y; Zheng Y; Zonies D; Zou X; Salomon JA; Lopez AD; Vos T
    Lancet; 2015 Nov; 386(10009):2145-91. PubMed ID: 26321261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
    Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
    Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Castaldelli-Maia JM; Wang YP; Brunoni AR; Faro A; Guimarães RA; Lucchetti G; Martorell M; Moreira RS; Pacheco-Barrios K; Rodriguez JAB; Roever L; Silva DAS; Tovani-Palone MR; Valdez PR; Zimmermann IR; Culbreth GT; Hay SI; Murray CJL; Bensenor IM
    Lancet Psychiatry; 2023 Feb; 10(2):85-97. PubMed ID: 36697127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.
    Aghaei AM; Gholami J; Sangchooli A; Rostam-Abadi Y; Olamazadeh S; Ardeshir M; Baheshmat S; Shadloo B; Taj M; Saeed K; Rahimi-Movaghar A
    Lancet Glob Health; 2023 Aug; 11(8):e1225-e1237. PubMed ID: 37474230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.